Blog
-

Proper Drug and Medication Disposal: Protecting People, Water, and Wildlife
Improper disposal of unused and expired medicines is a hidden environmental and public-health crisis. Millions of households, clinics, and long-term care facilities discard pharmaceuticals in ways that allow active drug ingredients to enter landfills, septic systems, wastewater treatment plants, and surface waters. These pathways spread bioactive chemicals into ecosystems, contribute to antimicrobial resistance, and increase…
-

Physical and mental health after a layoff
Losing a job can feel destabilizing for your finances and identity, and it commonly triggers anxiety, low mood, sleep disruption, and physical symptoms such as headaches or fatigue.1 This post gives clear, practical coping steps, an evidence-informed overview of over-the-counter and prescription options with pros/cons and side effects, and a short section on non-medical approaches…
-

Biosimilars, Generics, and the New Cost-Control Countertrend in Pharmaceuticals
Prescription drug prices have long been a primary concern for patients, payers, and policymakers worldwide. In recent years, the surge of biosimilars and generics has emerged as a leading force in reshaping the economics of the pharmaceutical industry, promising not only reduced costs but also greater competition and accessibility. As of 2025, this movement —…
-

Are Seasonal Immunizations for RSV, COVID-19, and Influenza Safe?
A Comprehensive, Science-Based Guide for 2025–2026 As respiratory virus season returns in 2025–2026, many individuals and families are concerned about the safety of immunizations for respiratory syncytial virus (RSV), COVID-19, and influenza. With millions of people at risk each year, vaccines are vital public health tools, but questions about their safety, potential side effects, and…
-

The ANDA Prioritization Pilot Is a Smart, Strategic Move to Rebuild U.S. Generic Drug Manufacturing Capacity
The Food and Drug Administration’s new ANDA Prioritization Pilot realigns regulatory incentives to reward onshore bioequivalence testing and U.S. manufacturing of finished dosage forms and active pharmaceutical ingredients (API), and it will strengthen supply‑chain resilience, lower inspection costs, and speed patient access to affordable generics. The policy leverages FDA review speed as a targeted market…
-

ADRIANA Pain Medication – A Promising Future Alternative to Opioids
The opioid crisis has devastated communities worldwide, particularly in the United States, where opioid overdoses claimed more than 80,000 lives in 2023 alone.¹ While opioids like morphine and oxycodone remain powerful tools for managing severe pain, their risks —including addiction, overdose, and long-term dependence — have created an urgent need for safer alternatives. Enter ADRIANA…
-

Fact-Checking Trump’s Autism Drug: Is Leucovorin a Breakthrough or Hype?
Leucovorin for Autism: Clinical Efficacy and Biochemical Mechanisms Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition, affecting communication, social interaction, and behavior, with rising global prevalence and substantial lifelong impact on families and public health systems.1 2 Despite decades of research, interventions addressing the core symptoms-language deficits, social challenges, and repetitive behaviors-remain limited. Leucovorin,…



